Search

everythinglearnresearchcommunity

for

Search:↓

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.

Skin emergency severity rises with other health issues and affects multiple organs; a new grading system can improve patient care.

Single-needle radiofrequency is effective and safe for treating facial sebaceous hyperplasia.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

Plum-blossom needling with conventional treatments improves hair regrowth in alopecia areata.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Boswellia sacra helped improve pilonidal sinus symptoms in one case.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Methotrexate is not proven to maintain remission in ulcerative colitis.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

Entospletinib effectively prevents eye and skin GVHD in mice.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Trichilemmal carcinoma shares genetic changes with other skin cancers, suggesting similar causes and potential treatments.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

Alopecia areata affects 1 in 50 people, with non-White ethnic groups experiencing the most impact on mental health and work.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

New treatments for seborrheic dermatitis show promise for difficult cases.

Premature graying of hair is mainly caused by genetics, stress, and environment, with potential treatments being explored.

Alopecia areata is unpredictable, with limited treatment effectiveness, especially in severe cases.

Behavioral interventions, especially habit reversal training, are most effective for treating trichotillomania in children.

Melasma treatment is difficult, but combination therapies and personalized plans show promise.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Hair loss in a child was an early sign of Crohn's disease.

New treatments for alopecia areata show promise but need ongoing use and have infection risks.

Tinea capitis in older adults is often misdiagnosed but can be effectively treated with antifungal therapy.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.